All systems go: converging synthetic biology and combinatorial treatment for CAR-T cell therapy
{{output}}
Synthetic biology has been transformative to the treatment of advanced hematological malignancies by chimeric antigen receptor (CAR)-engineered T cells. A range of obstacles are now understood to limit the responses of solid epithelial-derived tumors to CAR th... ...